Cited by 31Substance Abuse Treatment and OutcomesHIV, Drug Use, Sexual RiskHIV/AIDS Research and Interventions

Testing the effectiveness of a motivational interviewing-based brief intervention for substance use as an adjunct to usual care in community-based aids service organizations: study protocol for a multisite randomized controlled trial

Open access
Garner, Bryan R., Gotham, Heather J., Tueller, Stephen J., Ball, Elizabeth L., Kaiser, David, Stilen, Patricia, Speck, Kathryn, Vandersloot, Denna +4 more·2017·Addiction Science & Clinical Practice

Abstract

Background: In 2010, the first comprehensive National HIV/AIDS Strategy for the United States was released and included three goals: (1) reducing the number of people who become infected with HIV, (2) increasing access to care and improving health outcomes for people living with HIV, and (3) reducing HIV-related health disparities and health inequities. In 2013, as part of its effort to help address the National HIV/AIDS Strategy, the National Institute on Drug Abuse (NIDA) funded a type 2 effectiveness-implementation hybrid trial titled the Substance Abuse Treatment to HIV Care (SAT2HIV) Project. Aim 1 of the SAT2HIV Project tests the effectiveness of a motivational interviewing-based brief intervention (MIBI) for substance use as an adjunct to usual care within AIDS Service Organizations (ASOs) as part of its MIBI Experiment. Aim 2 of the SAT2HIV Project tests the effectiveness of implementation and sustainment facilitation (ISF) as an adjunct to the Addiction Technology Transfer Center (ATTC) model for training staff in motivational interviewing as part of its ISF Experiment. The current paper describes the study protocol for the MIBI Experiment. Methods: As part of a multisite randomized controlled trial, individuals with comorbid HIV/AIDS and problematic substance use are randomized to receive either the ASOs’ usual care (control condition) or usual care plus a MIBI for substance use (experimental condition) delivered by trained ASO case-management staff. Primary outcome measures are reductions in days of primary substance use, number of substance-related problems, times engaging in risky behaviors, days of non-adherence to HIV medications, and increases in substance use treatment. As part of this paper, we describe the trial protocol in accordance with the Standard Protocol Items: Recommendations for Interventional Trials guidelines. Discussion: If successfully able to implement MIBI as an effective adjunct to usual care, the current trial may have a significant impact on increasing the capacity of ASOs to address problematic substance use among individuals living with HIV/AIDS. Reducing the prevalence of problematic substance use among individuals living with HIV/AIDS within the United States may lead to significant improvements on key performance measures (i.e., the HIV Care Continuum and the 90-90-90 target). Trial registration ClinicalTrials.gov: NCT02495402

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s13722-017-0095-8

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In Garner et al. (2017), whole organizations were randomized to receive the implementation strategy rather than randomizing staff within the same organization.

    “In this scenario, whole organizations were randomized to receive the implementation strategy rather than randomizing staff within the same organization.”

    From An introduction to effectiveness-implementation hybrid designs (2019) · cites this paper as Garner et al. (2017)

    The Methods section (Assignment of interventions > Allocation; page unavailable) says client participants were randomized within each of the 39 organizations, rather than whole organizations being randomized to an implementation strategy. The Statistical methods section mentions an organization-level condition but does not say that organizations were randomized to it. (LLM, conf=0.85)

    Checked by a reasoning model — may be wrong.

    Experimental — accuracy not yet measured
  • Garner et al. (2017) provides an example of dual-randomization at both organizational and client level.

    “Garner et al. (2017) provides an example of dual-randomization at both the organizational and client level.”

    From An introduction to effectiveness-implementation hybrid designs (2019) · cites this paper as Garner et al. (2017)

    Methods > Assignment of interventions states that clients are randomized within each AIDS service organization. Methods > Data collection, management, and analysis mentions an organization-level condition, but does not say organizations were randomized to it. The organizational-randomization part of the claim is therefore unsupported by our copy. (LLM, conf=0.88)

    Experimental — accuracy not yet measured
  • Garner et al. (2017) tested the impact of an implementation strategy, implementation and sustainment facilitation (ISF), as an adjunct to training.

    “testing the impact of an implementation strategy, implementation and sustainment facilitation (ISF), as an adjunct to training”

    From An introduction to effectiveness-implementation hybrid designs (2019) · cites this paper as Garner et al. (2017)

  • Garner et al. (2017) tested the effectiveness of a motivational interviewing-based brief intervention (MIBI) for substance use as an adjunct to usual care (UC) in AIDS service organizations.

    “testing the effectiveness of a motivational interviewing-based brief intervention (MIBI) for substance use as an adjunct to usual care (UC) in AIDS service organizations”

    From An introduction to effectiveness-implementation hybrid designs (2019) · cites this paper as Garner et al. (2017)

  • To test effectiveness of MIBI, Garner et al. used a multisite randomized controlled two-group (UC vs. UC + MIBI) in which there was client-level assignment to the UC + MIBI condition.

    “To test effectiveness of the MIBI intervention, Garner et al. used a multisite randomized controlled two-group (UC vs. UC + MIBI) in which there was client-level assignment to the UC + MIBI condition.”

    From An introduction to effectiveness-implementation hybrid designs (2019) · cites this paper as Garner et al. (2017)

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 50 · Cited by 31

Research works printed but not linked: 1

  1. [68]Institute of Medicine Improving the quality of health care for mental and substance-use conditions: quality chasm series 2006 Washington, DC National Academy Press 20669433

Authors
Garner, B. R., Gotham, H. J., Tueller, S. J., Ball, E. L., Kaiser, D., Stilen, P., Speck, K., Vandersloot, D., Rieckmann, T. R., Chaple, M., Martin, E. G., & Martino, S.
Affiliations
  • RTI International (US)
  • University of Missouri–Kansas City (US)
  • University of Nebraska–Lincoln (US)
  • Oregon Health & Science University (US)
  • National Development and Research Institutes (US)
  • State University of New York (US)
  • Yale University (US)
Corresponding author
Garner, Bryan R.
Venue
Addiction Science & Clinical Practice
Published
2017-11-17
Volume
12
Issue
1
Pages
31-31
ISSN
  • 1940-0632 (ISSN-L)
  • 1940-0640
OpenAlex
W2769368130
Cited by
31
References
50
Citations by year
2026: 1 · 2025: 3 · 2024: 8 · 2023: 3 · 2022: 3 · 2021: 5 · 2020: 2 · 2019: 2 · 2018: 2 · 2017: 1 · 2014: 1
FWCI
1.50
Type
journal article
Language
en
Open access
Locations
  • Addiction Science & Clinical Practice (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
National Institute on Drug Abuse (R01-DA038146)
Topics
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
  • Health Sciences › Medicine › Epidemiology › HIV, Drug Use, Sexual Risk
  • Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
Keywords
motivational interviewing, brief intervention, substance use, HIV/AIDS, AIDS service organizations, substance use comorbidity, HIV care continuum, HIV treatment adherence, addiction treatment, case management, National HIV/AIDS Strategy, hybrid effectiveness-implementation trial
MeSH terms
Clinical Protocols, Female, Humans, Male, Motivation, Patient Education as Topic, Patient Participation, Research Design, United States, HIV Infections, Randomized Controlled Trials as Topic, Substance-Related Disorders, Motivational Interviewing, Patient Navigation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review